A multisite trial of a clinic-integrated intervention for promoting family management of pediatric type 1 diabetes: feasibility and design.

Pediatric Diabetes
Tonja R NanselAmanda Sobel Lochrie

Abstract

The feasibility of a family-based clinic-integrated behavioral intervention to improve family management of type 1 diabetes was evaluated. In each of four clinical sites, 30-32 families (a total of 122) were randomized to intervention or usual care comparison groups. The WE*CAN intervention, based on family problem-solving methods, was delivered during three routine clinic visits by trained 'Health Advisors'. Of eligible families across the four sites, 83% agreed to participate, of whom 96% completed the baseline, mid-term, and postintervention assessments. Families participated in an average of 2.85 intervention sessions over an 8-month period. The intervention was integrated into the clinic setting without impairing clinic flow and was implemented with fidelity and consistency across sites by trained non-professionals. The findings provide evidence of the feasibility of conducting a multisite trial to evaluate the effects of a clinic-integrated problem-solving intervention to improve family management. Many lessons were learned that provide guidance for recruitment, measurement, and intervention for the larger clinical trial.

References

Nov 9, 2001·Journal of Pediatric Psychology·P GrecoG Reeves
May 22, 2002·JAMA : the Journal of the American Medical Association·Arleta RewersGeorgeanna Klingensmith
Mar 21, 2003·Journal of Affective Disorders·Maria KovacsJoel Sherrill
Apr 25, 2003·The Journal of Pediatrics·Lori M B LaffelBarbara J Anderson
Oct 23, 2003·The Journal of Pediatrics·Bryan Lask
Feb 20, 2007·The Journal of Pediatrics·Britta M SvorenLori M B Laffel
Mar 21, 2007·Diabetes Care·Korey K HoodLori M B Laffel

❮ Previous
Next ❯

Citations

Sep 8, 2010·Current Diabetes Reports·Michael A HarrisDanny C Duke
Dec 26, 2012·Current Diabetes Reports·Orit Pinhas-Hamiel, Yael Levy-Shraga
May 22, 2010·Current Opinion in Pediatrics·Joshua S Borus, Lori Laffel
Oct 18, 2012·The Diabetes Educator·Carolyn T ThorpeEdwin B Fisher
Nov 21, 2015·Journal of Pediatric Nursing·Elizabeth Babler, Carolyn June Strickland
Aug 11, 2015·Child: Care, Health and Development·M E McGradyA L H Pai
Jan 15, 2013·Diabetes Research and Clinical Practice·Stephanie L FitzpatrickFelicia Hill-Briggs
Mar 21, 2013·Diabetic Medicine : a Journal of the British Diabetic Association·C EiserS Heller
Jan 17, 2013·Diabetic Medicine : a Journal of the British Diabetic Association·Y P WuK K Hood
Mar 31, 2011·Pediatric Diabetes·Jennifer M RohanDennis Drotar
Aug 17, 2011·Diabetic Medicine : a Journal of the British Diabetic Association·J T MarkowitzT Wysocki
Aug 10, 2011·Diabetic Medicine : a Journal of the British Diabetic Association·C R AlleynJ Weissberg-Benchell
Mar 30, 2016·Patient Education and Counseling·Neesha RamchandaniSusan Sullivan-Bolyai
Nov 27, 2014·Diabetic Medicine : a Journal of the British Diabetic Association·E J Mayer-DavisT Wysocki
Feb 7, 2016·The Diabetes Educator·Anastasia Albanese-O'NeillJennifer H Elder
Aug 10, 2016·The Diabetes Educator·Sébastien ColsonMarie-Claude Lagouanelle-Simeoni
Apr 16, 2015·The Cochrane Database of Systematic Reviews·Christopher EcclestonTonya M Palermo
Mar 19, 2019·The Cochrane Database of Systematic Reviews·Emily LawTonya M Palermo
Nov 30, 2019·Child: Care, Health and Development·Regitze Anne Saurbrey PalsDan Grabowski
Sep 18, 2015·Current Psychiatry Reports·Stuart B Murray, Leslie K Anderson
Jul 24, 2021·Journal of Pediatric Nursing·Joyce P Yi-FrazierFaisal S Malik
Jun 22, 2021·Diabetes Spectrum : a Publication of the American Diabetes Association·Arwen M MarkerSusana R Patton

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.